Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.
donanemab
Posted inClinical Trials, Neuroscience
Donanemab: Possible Treatment for Alzheimer’s Disease
The amyloid hypothesis, being verified by Eli Lilly, is not about to go away. However, the therapeutic achievements are still quite modest.
